Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls.

Strober M, DeAntonio M, Schmidt-Lackner S, Pataki C, Freeman R, Rigali J, Rao U.

J Clin Psychiatry. 1999 Mar;60(3):164-9.

PMID:
10192591
2.

A double-blind comparison of nefazodone, imipramine, and placebo in major depression.

Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.

J Clin Psychiatry. 1994 Jun;55(6):234-41.

PMID:
8071277
3.
4.
5.

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.

J Clin Psychiatry. 1999 Apr;60(4):226-31.

PMID:
10221282
6.
7.

Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.

Suri RA, Altshuler LL, Rasgon NL, Calcagno JL, Frye MA, Gitlin MJ, Hwang S, Zuckerbrow-Miller J.

J Clin Psychiatry. 2000 Dec;61(12):942-6.

PMID:
11206600
8.
9.

A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.

McGrath PJ, Stewart JW, Janal MN, Petkova E, Quitkin FM, Klein DF.

Am J Psychiatry. 2000 Mar;157(3):344-50.

PMID:
10698808
10.

Double-blind comparison of bupropion and fluoxetine in depressed outpatients.

Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.

J Clin Psychiatry. 1991 Aug;52(8):329-35.

PMID:
1907963
11.
12.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
14.

Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.

Thase ME, Blomgren SL, Birkett MA, Apter JT, Tepner RG.

J Clin Psychiatry. 1997 Jan;58(1):16-21.

PMID:
9055832
15.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
16.
17.
18.

Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?

Levitt AJ, Joffe RT, Kamil R, McIntyre R.

J Clin Psychiatry. 1999 Sep;60(9):613-6.

PMID:
10520980
19.

A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.

Corya SA, Perlis RH, Keck PE Jr, Lin DY, Case MG, Williamson DJ, Tohen MF.

J Clin Psychiatry. 2006 May;67(5):798-806.

PMID:
16841630
20.

Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.

Cornelius JR, Bukstein OG, Birmaher B, Salloum IM, Lynch K, Pollock NK, Gershon S, Clark D.

Addict Behav. 2001 Sep-Oct;26(5):735-9.

PMID:
11676382
Items per page

Supplemental Content

Write to the Help Desk